Salud

Cápsulas de Paxlovid contra covid-19 con autorización de venta en Costa Rica

Salud permite uso de emergencia. Combinación de pastillas se debe administrar dentro de los primeros cinco días siguientes a la aparición de los síntomas de la enfermedad

(FILES) This file handout photo provided to AFP on November 16, 2021 courtesy of Pfizer shows the making of its experimental Covid-19 antiviral pills inside his laboratory in Freiburg, Germany. - Pfizer said today that it will sell 10 million Covid-19 treatment courses for�Covid-19 to the US government for $5.3 billion, pending approval from regulators. The pharmaceutical giant asked the US Food and Drug Administration on November 16, 2021 for emergency use authorization for its Paxlovid pill which has been shown to cut hospitalization or death by nearly 90 percent among newly-infected high risk patients. (Photo by Handout / Pfizer / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO / Pfizer " - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS
(FILES) This file handout photo provided to AFP on November 16, 2021 courtesy of Pfizer shows the making of its experimental Covid-19 antiviral pills inside his laboratory in Freiburg, Germany. - Pfizer said today that it will sell 10 million Covid-19 treatment courses for�Covid-19 to the US government for $5.3 billion, pending approval from regulators. The pharmaceutical giant asked the US Food and Drug Administration on November 16, 2021 for emergency use authorization for its Paxlovid pill which has been shown to cut hospitalization or death by nearly 90 percent among newly-infected high risk patients. (Photo by Handout / Pfizer / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO / Pfizer " - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS HANDOUT
‌
‌

‌

‌
‌

‌

‌